EP2 receptor stimulation promotes calcium responses in astrocytes via activation of the adenylyl cyclase pathway

被引:15
|
作者
Di Cesare, A.
Del Piccolo, P.
Zacchetti, D.
Grohovaz, F.
机构
[1] Ist Sci San Raffaele, Dibit, ITT Res Unit Mol Neurosci, I-20132 Milan, Italy
[2] Vita Salute San Raffaele Univ, Milan, Italy
关键词
prostaglandin E-2; butaprost; sulprostone; isoproterenol; forskolin; cAMP;
D O I
10.1007/s00018-006-6262-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Astrocytes are a heterogeneous population of cells that are endowed with a great variety of receptors for neurotransmitters and neuromodulators. Recently prostaglandin E-2 has attracted great interest since it is not only released by astrocytes but also activates receptors coupled to either phospholipase C or adenylyl cyclase. We report that EP2 receptor stimulation triggers cAMP production but also causes release of Ca2+ from intracellular stores. This effect is shared by other receptors similarly coupled to adenylyl cyclase and elicited by direct stimulation of the enzyme or application of cAMP analogues. However, the stimulation of the Ca2+ response by cAMP is not mediated by protein kinase A, since a specific antagonist of this kinase had no effect. Such a cross-talk between cAMP and Ca2+ was not observed in all astrocytes. It might therefore reflect a specific resource of either a subpopulation or astrocytes in a specific functional state.
引用
收藏
页码:2546 / 2553
页数:8
相关论文
共 50 条
  • [1] EP2 receptor stimulation promotes calcium responses in astrocytes via activation of the adenylyl cyclase pathway
    A. Di Cesare
    P. Del Piccolo
    D. Zacchetti
    F. Grohovaz
    Cellular and Molecular Life Sciences CMLS, 2006, 63 : 2546 - 2553
  • [2] EP2 receptor mediated cAMP release is augmented by PGF2α activation of the FP receptor via the calcium-calmodulin pathway
    Abera, A. B.
    Sales, K. J.
    Catalano, R. D.
    Katz, A. A.
    Jabbour, H. N.
    CELLULAR SIGNALLING, 2010, 22 (01) : 71 - 79
  • [3] Prostaglandin-stimulated adenylyl cyclase activity via a pharmacologically defined EP2 receptor in human nonpigmented ciliary epithelial cells
    Crider, JY
    Griffin, BW
    Sharif, NA
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 1998, 14 (04) : 293 - 304
  • [4] Promotion of adipogenesis by an EP2 receptor agonist via stimulation of angiogenesis in pulmonary emphysema
    Tsuji, Takao
    Yamaguchi, Kazuhiro
    Kikuchi, Ryota
    Itoh, Masayuki
    Nakamura, Hiroyuki
    Nagai, Atsushi
    Aoshiba, Kazutetsu
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2014, 112 : 9 - 15
  • [5] STIMULATION OF CAMP IN PROMYELOCYTIC HL-60 CELLS BY PROSTAGLANDIN EP2 RECEPTOR ACTIVATION
    HOLLINGSWORTH, N
    DEVRIES, GW
    FASEB JOURNAL, 1992, 6 (05): : A1849 - A1849
  • [6] EP2 receptor-mediated cAMP release is augmented following activation of the calcium-calmodulin pathway by PGF2α-FP receptor interaction
    Abera, Aron
    Sales, Kurt
    Catalano, Oberto
    Katz, Arieh
    Jabbour, Henry
    BIOLOGY OF REPRODUCTION, 2008, : 98 - 98
  • [7] Receptor-coupled phospholipase C and adenylyl cyclase function with different calcium pools in astrocytes
    Balázs, R
    Miller, S
    Chun, Y
    Cotman, CW
    NEUROREPORT, 1998, 9 (07) : 1397 - 1401
  • [8] Prostaglandin E2 Promotes Wound-Induced Migration of Intestinal Subepithelial Myofibroblasts via EP2, EP3, and EP4 Prostanoid Receptor Activation
    Iwanaga, Koichi
    Okada, Muneyoshi
    Murata, Takahisa
    Hori, Masatoshi
    Ozaki, Hiroshi
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2012, 340 (03): : 604 - 611
  • [9] Ocular inflammatory responses in the EP2 and EP4 receptor knockout mice
    Biswas, S.
    Bhattacherjee, P.
    Paterson, C. A.
    Tilley, S. L.
    Koller, B. H.
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2006, 14 (03) : 157 - 163
  • [10] Compartmentalized cAMP responses to prostaglandin EP2 receptor activation in human airway smooth muscle cells
    Agarwal, Shailesh R.
    Miyashiro, Kathryn
    Latt, Htun
    Ostrom, Rennolds S.
    Harvey, Robert D.
    BRITISH JOURNAL OF PHARMACOLOGY, 2017, 174 (16) : 2784 - 2796